🇺🇸 FDA
Patent

US 11230565

Synthesis of backbone modified morpholino oligonucleotides and chimeras using phosphoramidite chemistry

granted A61PA61P43/00

Quick answer

US patent 11230565 (Synthesis of backbone modified morpholino oligonucleotides and chimeras using phosphoramidite chemistry) held by The Regents of the University of Colorado expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P43/00